CME Group Inc. CME
308.27 USD +4.21 (+1.38%)
At closeNov 4, 2026, 5:30 PM EST
308.27 0.00 0.00%
After hours · Nov 4, 5:30 PM ET
300.29 Day range 308.38
218.31 52-week range 329.16
- YTD
- +12.89%
- 1 year
- +15.09%
Analyst view
Consensus: buy
Buy
Price target (mean) 317.06 +2.9% upside
Now 308.27
- Target (low)
- 227.00
- Target (mean)
- 317.06
- Target (high)
- 367.00
Ratings (0m) 17 9 buy · 6 hold · 2 sell
- Strong buy5
- Buy4
- Hold6
- Sell1
- Strong sell1
Recommendation trend
- This month 17
- 1 month ago 17
- 2 months ago 16
- 3 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 3.03 | 2.92 – 3.28 | 2.77 | +9.2% | 1.76B | +6.9% | 14 |
| Next quarter | 3.32 | 3.05 – 3.60 | 3.36 | -1.2% | 1.86B | -1.1% | 12 |
| Current year | 12.40 | 12.29 – 12.66 | 11.20 | +10.7% | 7.09B | +8.7% | 15 |
| Next year | 13.23 | 12.38 – 13.70 | 12.40 | +6.7% | 7.47B | +5.4% | 16 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 22, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 22, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Oct 22, 2026 | JP Morgan | Upgrade | Underweight | Overweight |
| Oct 14, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 9, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 5, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 2, 2026 | Wells Fargo | Initiated | — | Overweight |
| Sep 28, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Sep 3, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Aug 19, 2026 | Deutsche Bank | Downgrade | Buy | Hold |
| Jul 23, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Jul 23, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| Jul 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 9, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 2, 2026 | Raymond James | Reiterated | Outperform | Outperform |
| Jun 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jun 18, 2026 | Keefe, Bruyette & Woods | Upgrade | Market Perform | Outperform |
| Jun 11, 2026 | Rothschild & Co | Upgrade | Neutral | Buy |
| Jun 5, 2026 | Erste Group | Downgrade | Buy | Hold |
| Apr 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 23, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
